Inozyme Pharma (NASDAQ:INZY – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at Needham & Company LLC in a research report issued to clients and investors on Friday, Benzinga reports. They presently have a $23.00 price target on the stock. Needham & Company LLC’s price target indicates a potential upside of […]

Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a research note issued on Wednesday, Benzinga reports. They presently have a $10.00 price target on the biopharmaceutical company’s stock. HC Wainwright’s price target points to a potential upside of 443.48% from the stock’s previous […]

Marinus Pharmaceuticals (NASDAQ:MRNS – Get Free Report) had its price objective lowered by analysts at Cantor Fitzgerald from $13.00 to $4.00 in a report issued on Friday, Benzinga reports. The brokerage presently has an “overweight” rating on the biopharmaceutical company’s stock. A number of other brokerages also recently commented on MRNS. LADENBURG THALM/SH SH downgraded […]

SmartFinancial (NASDAQ:SMBK – Get Free Report) had its price target hoisted by Hovde Group from $28.00 to $32.50 in a report released on Wednesday, MarketBeat Ratings reports. The firm currently has a “market perform” rating on the bank’s stock. Hovde Group’s price objective would indicate a potential upside of 0.46% from the company’s previous close. […]

Lockheed Martin (NYSE:LMT – Get Free Report) had its price target dropped by equities researchers at Susquehanna from $705.00 to $695.00 in a note issued to investors on Wednesday, Benzinga reports. The firm presently has a “positive” rating on the aerospace company’s stock. Susquehanna’s price objective indicates a potential upside of 23.18% from the company’s […]

Restore (LON:RST – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at Canaccord Genuity Group in a research report issued to clients and investors on Friday, Digital Look reports. They presently have a GBX 380 ($4.93) target price on the stock. Canaccord Genuity Group’s target price would indicate a potential upside […]

Herc (NYSE:HRI – Get Free Report) had its price objective increased by investment analysts at Barclays from $175.00 to $250.00 in a report issued on Wednesday, Benzinga reports. The firm presently has an “overweight” rating on the transportation company’s stock. Barclays‘s price objective would indicate a potential upside of 19.54% from the company’s previous close. […]

Wave Life Sciences (NASDAQ:WVE – Free Report) had its target price upped by Royal Bank of Canada from $7.00 to $15.00 in a research note published on Monday morning, Benzinga reports. The brokerage currently has a sector perform rating on the stock. Other equities analysts have also issued reports about the company. Mizuho reissued an […]

EF Hutton Acquisition Co. I upgraded shares of NRx Pharmaceuticals (NASDAQ:NRXP – Free Report) to a strong-buy rating in a research report sent to investors on Monday morning, Zacks.com reports. Other analysts also recently issued research reports about the stock. Ascendiant Capital Markets raised their price objective on shares of NRx Pharmaceuticals from $43.00 to […]

HC Wainwright reaffirmed their buy rating on shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) in a research note released on Monday morning, Benzinga reports. The firm currently has a $600.00 target price on the pharmaceutical company’s stock. Several other analysts have also recently weighed in on the stock. Needham & Company LLC reissued a […]

Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) had its price target dropped by equities research analysts at Chardan Capital from $94.00 to $88.00 in a report released on Thursday, Benzinga reports. The firm currently has a “buy” rating on the stock. Chardan Capital’s target price would suggest a potential upside of 455.21% from the stock’s […]

Voyager Therapeutics (NASDAQ:VYGR – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a research note issued on Thursday, Benzinga reports. They currently have a $30.00 price objective on the stock. HC Wainwright’s price objective would suggest a potential upside of 358.02% from the stock’s current price. Other […]

GE Vernova (NYSE:GEV – Get Free Report) had its price target boosted by analysts at Truist Financial from $300.00 to $325.00 in a report released on Thursday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Truist Financial’s target price indicates a potential upside of 9.43% from the stock’s current price. A […]

Clene (NASDAQ:CLNN – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a research report issued to clients and investors on Thursday, Benzinga reports. They currently have a $31.00 target price on the stock. HC Wainwright’s price target would suggest a potential upside of 474.07% from the company’s […]